SEARCH:   Advanced

Blood, Vol. 112, Issue 9, 3847-3855, November 1, 2008 This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance Blood Iacobucci et al. 112: 3847 Supplemental materials for: Iacobucci et al Files in this Data Supplement: Figure S1. Apoptotic rates of untreated and TKI- (imatinib, nilotinib and dasatinib) treated cells (JPG, 290 KB) - Treatment with TKIs increased the apoptotic rate in Ikaros full length expressing-cells (SD-1), whereas no differences were identified in Ik6 expressing-cells (BV-173) between untreated and TKI-treated cells. This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef

	Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020